Correction to: Leukemia https://doi.org/10.1038/sj.leu.2403653
Following the publication of this article, the authors noted an error in the labelling of Fig. 1e. The patient sample labelled 8 should have been 18. For clarification, the untreated sample (left hand) lane is intentionally the same image as patient sample 18 in Fig. 1d; the sample in the right hand lane has been treated with LY294002 as indicated, to depict the reduction in pAkt Thr 308 levels.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grandage, V.L., Gale, R.E., Linch, D.C. et al. Correction: PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways. Leukemia 36, 296 (2022). https://doi.org/10.1038/s41375-021-01440-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-021-01440-w